# US 2026/0092332 A1 · Skin microbiome-based methods for acne assessment and treatment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0092332 A1
- Document ID: US20260092332A1
- Status: Published application
- Kind: A1
- Application number: 19/338,761
- Filed: 2025-09-24
- Published: 2026-04-02
- Earliest claimed: 2024-10-01
- Assignees: L'oreal; The Regents of the University of California
- Applicants: L'oreal; The Regents of the University of California
- Inventors: Amina BOUSLIMANI; Sayeh POURHAMIDI; Magali MOREAU; Jolanta IDKOWIAK-BALDYS; Susi DAL BELO; Se Jin SONG; Tyler MYERS; Andrew BARTKO
- Web page: https://patentgrep.com/patent/US20260092332A1

## CPC

- C12Q 1/689: for bacteria
- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2600/106: Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods for identifying an individual having a predisposition to developing acne, for assessing severity of acne lesions, and for personalized prevention, diagnosis, and treatment of acne are disclosed. The methods include: (a) obtaining microbiome sample from skin of an individual; (b) determining an amount of one or more bacteria in the microbiome sample, wherein the one or more bacteria are selected from Lawsonella, Cutibacterium, Staphylococcus, Corynebacterium, Streptococcus, Micrococcus, and Neisseriaceae; (c) comparing the amount of the one or more bacteria to a control; and (d) identifying a difference between the amount of the one or more bacteria in the microbiome sample and the control.

## Claims

### Claim 1

A method for identifying an individual having a predisposition to developing acne, the method comprising:
(a) obtaining microbiome sample from skin of an individual;
(b) determining an amount of one or more bacteria in the microbiome sample, wherein the one or more bacteria are selected from Lawsonella, Cutibacterium, Staphylococcus, Corynebacterium, Streptococcus, Micrococcus, and Neisseriaceae, preferably wherein the one or more bacteria include Lawsonella, Cutibacterium, or a combination thereof;
(c) comparing the amount of the one or more bacteria to a control;
(d) identifying a difference between the amount of the one or more bacteria in the microbiome sample and the control with respect to at least one bacteria selected from Lawsonella, Cutibacterium, Staphylococcus, Corynebacterium, Streptococcus, Micrococcus, and Neisseriaceae, preferably wherein the at least one bacteria include Lawsonella, Cutibacterium, or a combination thereof; and
(c) identifying the individual having a predisposition to developing acne based on the difference.

### Claim 2 (depends on 1)

The method of claim 1, wherein the control is an amount of bacteria in a microbiome sample from a population of individuals not suffering from acne, wherein the bacteria is at least one bacteria selected from Lawsonella, Cutibacterium, Staphylococcus, Corynebacterium, Streptococcus, Micrococcus, and Neisseriaceae, preferably wherein the at least one bacteria is Lawsonella, Cutibacterium, or a combination thereof.

### Claim 3 (depends on 1)

The method of claim 1, further comprising, treating the individual having a predisposition to developing acne by minimizing the difference between amounts of the bacteria in the microbiome of the individual's skin and the control.

### Claim 4 (depends on 3)

The method of claim 3, wherein the treatment comprises topically administering to the individual's skin a pharmaceutical or cosmetic composition that minimizes the difference between amounts of the bacterial in the microbiome of the individual's skin and the control.

### Claim 5 (depends on 4)

The method of claim 4, wherein the pharmaceutical or cosmetic composition includes one or more anti-acne compounds selected from retinoids, anti-bacterial compounds, anti-inflammatory compounds, essential oils, a botanical extracts, probiotics, prebiotics, postbiotics, metabolites, vitamins, benzoyl peroxide, sulfur, or combinations thereof.

### Claim 6 (depends on 3)

The method of claim 3, wherein the treatment comprising orally administering an active compound that minimizes the difference between the amounts of the bacterial in the microbiome of the individual's skin and the control.

### Claim 7 (depends on 6)

The method of claim 6, wherein the compound is a retinoid, an antibiotic, a hormone, a zinc salt, a prebiotic, a probiotic, an omega-3-fatty acid, a vitamin, or combinations thereof.

### Claim 8

A method for determining severity of acne lesions for an individual suffering from acne, the method comprising:
(a) obtaining microbiome sample from skin of the individual suffering from acne;
(b) determining an amount of one or more bacteria in the microbiome sample, wherein the bacteria are selected from Lawsonella, Cutibacterium, Staphylococcus, Corynebacterium, Streptococcus, Micrococcus, and Neisseriaceae, preferably wherein the one or more bacteria include Lawsonella, Cutibacterium, or a combination thereof;
(c) comparing the amount of the one or more bacteria to a control;
(d) identifying how the amount of the one or more bacteria in the microbiome sample differs from the control with respect to an amount of at least one bacteria selected from Lawsonella, Cutibacterium, Staphylococcus, Corynebacterium, Streptococcus, Micrococcus, and Neisseriaceae, preferably wherein the at least one bacteria include Lawsonella, Cutibacterium, or a combination thereof; and
(e) and determining the severity of the acne lesions based on the difference.

### Claim 9 (depends on 8)

The method of claim 8, wherein the control is an amount of bacteria in a microbiome sample from a population of individuals not suffering from acne, wherein the bacteria is at least one bacteria selected from Lawsonella, Cutibacterium, Staphylococcus, Corynebacterium, Streptococcus, Micrococcus, and Neisseriaceae, preferably wherein the at least one bacteria is Lawsonella, Cutibacterium, or a combination thereof.

### Claim 10 (depends on 8)

The method of claim 8, further comprising, treating the individual suffering from acne by minimizing the difference between amounts of the bacteria in the microbiome of the individual's skin and the control.

### Claim 11 (depends on 10)

The method of claim 10, wherein the treatment comprises topically administering to the individual's skin a pharmaceutical or cosmetic composition that minimizes the difference between amounts of the bacterial in the microbiome of the individual's skin and the control.

### Claim 12 (depends on 11)

The method of claim 11, wherein the pharmaceutical or cosmetic composition includes one or more anti-acne compounds selected from retinoids, anti-bacterial compounds, anti-inflammatory compounds, essential oils, a botanical extracts, probiotics, prebiotics, postbiotics, metabolites, vitamins, benzoyl peroxide, sulfur, or combinations thereof.

### Claim 13 (depends on 10)

The method of claim 10, wherein the treatment comprising orally administering an active compound that minimizes the difference between the amount of the bacterial in the microbiome of the individual's skin and the control.

### Claim 14 (depends on 13)

The method of claim 13, wherein the compound is a retinoid, an antibiotic, a hormone, a zinc salt, a prebiotic, postbiotics, metabolites, a probiotic, an omega-3-fatty acid, a vitamin, or combinations thereof.

### Claim 15

A method for personalized prevention and treatment of acne comprising:
(a) obtaining microbiome sample from skin of an individual;
(b) determining an amount of one or more bacteria in the microbiome sample, wherein the one or more bacteria are selected from Lawsonella, Cutibacterium, Staphylococcus, Corynebacterium, Streptococcus, Micrococcus, and Neisseriaceae, preferably wherein the one or more bacteria include Lawsonella, Cutibacterium, or a combination thereof;
(c) comparing the amount of the one or more bacteria to a control;
(d) identifying a difference between the amount of the one or more bacteria in the microbiome sample and the control with respect to at least one bacteria selected from Lawsonella, Cutibacterium, Staphylococcus, Corynebacterium, Streptococcus, Micrococcus, and Neisseriaceae, preferably wherein the at least one bacteria include Lawsonella, Cutibacterium, or a combination thereof; and
(c) treating the individual by minimizing the difference between amounts of the one or more bacteria in the microbiome of the individual's skin and the control.

### Claim 16 (depends on 15)

The method of claim 15, wherein the control is an amount of bacteria in a microbiome sample from a population of individuals not suffering from acne, wherein the bacteria is at least one bacteria selected from Lawsonella, Cutibacterium, Staphylococcus, Corynebacterium, Streptococcus, Micrococcus, and Neisseriaceae, preferably wherein the at least one bacteria is Lawsonella, Cutibacterium, or a combination thereof.

### Claim 17 (depends on 16)

The method of claim 16, wherein the treatment comprises topically administering to the individual's skin a pharmaceutical or cosmetic composition that minimizes the difference between the amount of the bacterial in the microbiome of the individual's skin and the control.

### Claim 18 (depends on 17)

The method of claim 17, wherein the pharmaceutical or cosmetic composition includes one or more anti-acne compounds selected from retinoids, anti-bacterial compounds, anti-inflammatory compounds, essential oils, a botanical extracts, probiotics, prebiotics, postbiotics, metabolites, vitamins, benzoyl peroxide, sulfur, or combinations thereof.

### Claim 19 (depends on 15)

The method of claim 15, wherein the treatment comprising orally administering an active compound that minimizes the difference between the amount of the bacterial in the microbiome of the individual's skin and the control.

### Claim 20 (depends on 19)

The method of claim 19, wherein the compound is a retinoid, an antibiotic, a hormone, a zinc salt, a prebiotic, a probiotic, an omega-3-fatty acid, a vitamin, or combinations thereof.
